Preventive or therapeutic agent for inflammatory bowel disease comprising IL-6 antagonist as an active ingredient
US7824674B2 · kind B2 · utility
72Cited by
7References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2003 |
| Grant date | Nov 2, 2010 |
| Priority date | — |
| Expiry date | Oct 3, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A preventive or therapeutic agent for inflammatory bowel disease such as Crohn's disease and ulcerative colitis said agent comprising as an active ingredient an interleukin-6 (IL-6) antagonist such as an antibody directed against IL-6 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.